In AML, NKL homeobox genes DLX1 and DLX2 are aberrantly activated via the ERK-pathway, and NANOG via stem cell factors STAT3 and TET2 and the NOTCH-pathway [18, 19], thus illustrating a wide diversity of deregulation modes. Here, DLX2 is linked to acute myeloid leukemia.